CD BioSciences Developed a Systematic Platform for Transgenesis in C. elegans Using MosSCI Method

December 09 21:51 2022
C.elegans platform announced the release of its systematic platform for transgenesis in c-elegans with MosSCI methods.

New York, USA – December 9, 2022 – C.elegans platform, the division of CD BioSciences, is a professional provider of C. elegans model services committed to providing researchers the most reliable research services with comprehensive data analysis, faster turnaround time, and the most competitive prices, including C. elegans genome editing, the construction of C. elegans stress response model, aging research, drug screening, and C. elegans biology among others. Recently, C.elegans platform announced the release of its systematic platform for transgenesis in c-elegans with MosSCI methods.

CD BioSciences offers a broad portfolio of comprehensive laboratory and manufacturing services, particularly for custom C. elegans models. CD BioSciences strives to find solutions that can improve research outcomes and significantly increase the speed of success to help study the molecular mechanisms of metabolic diseases, as well as drug screening for different diseases.

With a broad portfolio of comprehensive laboratory and manufacturing services, especially C. elegans model customization services, CD BioSciences has developed a systematic platform for C. elegans transgenesis using the MosSCI approach. The highly developed mosSCI system is a key technology for applications such as synthetic reporter genes and rapid testing of gene rescue constructs, especially when germline expression is required.

Genome editing tools based on the CRISPR-Cas9 system are a breakthrough technology that can precisely modify genomes in a relatively simple manner. CD BioSciences offers a range of CRISPR/Cas9 C. elegans model customization services that are part of an integrated portfolio of custom C. elegans model development services.

CD BioSciences offers commercially synthesized siRNAs that can silence virtually any gene in C. elegans, significantly accelerating the pace of research. The available services include RNAi design and synthesis services, RNAi transfection optimization services, and RNAi interference effects detection services.

In addition, CD BioSciences has developed a well-established platform for generating targeted gene knockouts in C. elegans using MosDel, specifically for custom C. elegans model services, that can be optimized to experimental specifications.

“Our customers can obtain genetically engineered C. elegans, and our team has always aimed to bring great convenience to customers with high-quality data delivery and in-depth scientific and technological support.” said Marcia Brady, the marketing director of CD BioSciences, she also added, “In addition, we also provide custom services to meet the special needs of customer research.”

About CD BioSciences

CD BioSciences is dedicated to helping our clients to achieve effective and successful research. We aim to providing our customers with high-quality data delivery, in-depth scientific and technical support. Our professional team is capable to offer comprehensive and systematic services that contribute to the better use of C. elegans for researchers.

Media Contact
Company Name: CD BioSciences
Contact Person: Marcia Brady
Email: Send Email
Phone: 1-631-372-1052
Country: United States
Website: https://www.elegansmodel.com

  Categories: